A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry

Shuang-huang-lian injection (SHLI) is a famous Chinese patent medicine, which has been wildly used in clinic to treat acute respiratory tract infection, pneumonia, influenza, and so forth. Despite the widespread clinical application, the prototype components and metabolites of SHLI have not been ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mingxing, Zhao, Baosheng, Liu, Haiyu, Zhang, Li, Peng, Long, Qin, Lingling, Zhang, Zhixin, Li, Jian, Cai, Chengke, Gao, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955581/
https://www.ncbi.nlm.nih.gov/pubmed/24719777
http://dx.doi.org/10.1155/2014/241505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955581/
https://www.ncbi.nlm.nih.gov/pubmed/24719777
http://dx.doi.org/10.1155/2014/241505

Ejemplares similares